Autoimmunity in inflammatory bowel disease: a holobiont perspective
Taylor H. et al, (2025), Current Opinion in Immunology, 94
Oxford spinal sarcoma service: excellent oncological outcomes with a centralised multidisciplinary approach to primary spinal tumour care
Tan JJH. et al, (2025), European Spine Journal
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.
Marshall JL. et al, (2025), Nat Commun, 16
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)
Lucinde R. et al, (2025), Wellcome Open Research, 7, 269 - 269
CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue.
Liu F. et al, (2025), Ann Rheum Dis
Small-molecule dissolution of stress granules by redox modulation benefits ALS models.
Uechi H. et al, (2025), Nat Chem Biol
'Treat-to-target': a call for earlier targeted intervention in asthma.
Couillard S. et al, (2025), J Allergy Clin Immunol Pract
Immune–epithelial–stromal networks define the cellular ecosystem of the small intestine in celiac disease
FitzPatrick MEB. et al, (2025), Nature Immunology
Use of polyethylene glycol precipitation and ultracentrifugation to enhance the sensitivity of hepatitis B virus DNA detection.
Fu MX. et al, (2025), J Clin Virol, 178
Community engagement and chronic viral hepatitis public health interventions: a systematic review, meta-analysis, and complementary crowdsourcing open call
Li Y. et al, (2025), eClinicalMedicine, 83, 103234 - 103234
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores
Vogelmeier CF. et al, (2025), Respiratory Medicine, 241, 108015 - 108015
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.
Zwerwer LR. et al, (2025), Nature communications, 16
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
Sciurba FC. et al, (2025), The New England journal of medicine, 392, 1710 - 1720
Pneumothorax: An update on clinical spectrum, diagnosis and management
Iqbal B. et al, (2025), Clinical Medicine, 25, 100327 - 100327